Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
284,444
-
Shares change
-
+9,655
-
Total reported value, excl. options
-
$327,598
-
Value change
-
+$11,438
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$1.16
Significant Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q2 2023
10 filings reported holding KZIA - KAZIA THERAPEUTICS LTD - American Depository Shares as of Q2 2023.
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 284,444 shares
of 1,786,081 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (204,550 shares), ACADIAN ASSET MANAGEMENT LLC (68,224 shares), RHUMBLINE ADVISERS (7,555 shares), BNP PARIBAS ARBITRAGE, SNC (3,298 shares), NewEdge Advisors, LLC (500 shares), BANK OF AMERICA CORP /DE/ (200 shares), Allworth Financial LP (87 shares), Steward Partners Investment Advisory, LLC (25 shares), AdvisorNet Financial, Inc (5 shares), and Belpointe Asset Management LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.